Evidence map›Paper›PMID 36896716›Full record

ArticleCirculation. Heart failure2023

In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility.

Juan B Ivey-Miranda, Veena S Rao, Zachary L Cox, Julieta Moreno-Villagomez, Devin Mahoney, Christopher Maulion, Lavanya Bellumkonda, Jeffrey M Turner, Sean Collins, F Perry Wilson and 2 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Circulation. Heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02546583 (Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02546583 phase1completednot on this map

Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure

TypeinterventionalSponsorYale UniversityRan2015 to 2020Enrolled458ConditionsHeart FailureArmsIncreased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide), IV Chlorothiazide
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Updates in Hospital Medicine.Journal of Brown hospital medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Juan B Ivey-MirandaDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.ORCID 0000-0001-8800-7298
Veena S RaoDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.
Zachary L CoxDepartment of Pharmacy Practice, Lipscomb University College of Pharmacy, Nashville, TN (Z.L.C.).ORCID 0000-0002-4919-0146
Julieta Moreno-VillagomezDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.ORCID 0000-0001-6966-8795
Devin MahoneyDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.ORCID 0000-0001-9059-1083
Christopher MaulionDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-2510-4266
Lavanya BellumkondaDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-9317-9067
Jeffrey M TurnerDepartment of Medicine, Division of Nephrology (J.M. Turner), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-5733-949X
Sean CollinsDepartment of Emergency Medicine (S.C.), Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-2305-9836
F Perry WilsonClinical and Translational Research Accelerator (F.P.W.), Yale University School of Medicine, New Haven, CT.ORCID 0000-0002-2633-2412
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT (H.M.K.).ORCID 0000-0003-2046-127X
Jeffrey M TestaniDepartment of Internal Medicine, Section of Cardiovascular Medicine (J.B.I.-M., V.S.R., J.M.-V., D.M., C.M., L.B., J.M. Testani), Yale University School of Medicine, New Haven, CT.ORCID 0000-0001-5285-0419
Cardiovascular Research Center · BRMaine Farmland Trust · USYale University · USLipscomb University · USMexican Social Security Institute · MXVanderbilt University Medical Center · USYale New Haven Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Mechanism and Effects of Manipulating Chloride Homeostasis in Heart FailureR01HL139629 · NHLBI · YALE UNIVERSITY · PI JEFFREY M TESTANI · 2018 to 2026
$5.0M
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart FailureR01HL128973 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2015 to 2019
$3.8M
Cardio-Renal Effects of Torsemide vs. Furosemide: A TRANSFORM-HF Mechanistic Sub-StudyR01HL148354 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2019 to 2022
$3.3M
Optimizing Electronic Alerts for Acute Kidney InjuryR01DK113191 · NIDDK · YALE UNIVERSITY · PI WILSON, FRANCIS PERRY · 2018 to 2022
$3.1M
Cardio-renal phenotype and prognosis in chronic heart failureK23HL114868 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2012 to 2017
$845k
Urine galectin-3 as a biomarker of cardio-renal phenotype and prognosisR21HL143092 · NHLBI · YALE UNIVERSITY · PI RAO, VEENA, TESTANI, JEFFREY M · 2018 to 2019
$251k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K23 HL114868NHLBI NIH HHS L30 HL115790NHLBI NIH HHS R01 HL128973NHLBI NIH HHS R01 HL139629NHLBI NIH HHS R01 HL148354NHLBI NIH HHS R21 HL143092NIDDK NIH HHS R01 DK113191
6 · The paper itself

Abstract

backgroundFollowing treatment for acute decompensated heart failure, in-hospital observation on oral diuretics (OOD) is recommended, assuming it provides actionable information on discharge diuretic dosing and thus reduces readmissions.

methodsIn the Mechanisms of Diuretic Resistance (MDR) cohort, we analyzed in-hospital measures of diuretic response, provider's decisions, and diuretic response ≈30 days postdischarge. In a Yale multicenter cohort, we assessed if in-hospital OOD was associated with 30-day readmission risk. The main objective of this study was to evaluate the utility of in-hospital OOD.

resultsOf the 468 patients in the MDR cohort, 57% (N=265) underwent in-hospital OOD. During the OOD, weight change and net fluid balance correlated poorly with each other (

conclusionsIn-hospital OOD did not provide actionable information on diuretic response, was not associated with outpatient dose selection, did not predict subsequent outpatient diuretic response, and was not associated with lower readmission rate. Additional research is needed to replicate these findings and understand if these resources could be better allocated elsewhere. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02546583.

Indexed as

DiureticsHeart FailureAftercareHospitalsHumansPatient DischargeTreatment OutcomeDiureticsdiureticsheart failurenatriuresisoutpatientpatient readmission

Identifiers

PMID36896716
PMCPMC10186250
OpenAlexW4323810437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.